GHIT Fund announced that it has decided to invest a total of about 1.37 billion yen in seven new drug developments for malaria, Chagas disease, schistosomiasis, soil-transmitted parasite disease, Buruli ulcer, and cutaneous leishmaniasis. Did.

https://www.ghitfund.org/newsroom/press/detail/290/j